Millendo Therapeutics, Inc.
MLND · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,511 | -$7,870 | -$10,860 | -$15,724 |
| Dep. & Amort. | $66 | $67 | $68 | -$241 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $61 | $1,092 | $1,389 | $3,412 |
| Change in WC | $968 | -$1,064 | $0 | -$33,600 |
| Other Non-Cash | $18,883 | $15,811 | $9,403 | $65,857 |
| Operating Cash Flow | $16,467 | $8,036 | $0 | $19,704 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$351 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | -$8 |
| Investing Cash Flow | $0 | $0 | $0 | -$359 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | -$1,892 | $3,570 | $1,443 | -$1,351 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $13 | $1,200 | -$721 | -$31,351 |
| Financing Cash Flow | $13 | $1,200 | -$721 | -$31,351 |
| Forex Effect | $0 | $0 | $0 | -$79 |
| Net Chg. in Cash | -$6,766 | -$7,231 | -$8,757 | -$37,747 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $14,723 | $21,954 | $30,711 | $68,458 |
| End Cash | $7,957 | $14,723 | $21,954 | $30,711 |
| Free Cash Flow | $16,467 | $8,036 | $0 | $19,353 |